Asia-Pacific
Abbvie Places $2 Billion Bet on Flourishing Immunotherapy Area with this Oncology Partnership
2020-09-06
Combating the Pandemic via AI and Diagnostics: Highlights from the “TAIWAN is Helping: AI x Pandemic Prevention Online Forum”
2020-08-11Partner
Australia-Taiwan Clinical Trial and Biomedical Forum, Highlights Synergies
2020-07-30Partner
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02